The Library
Rosiglitazone as a therapeutic agent to reduce inflammatory risk in type 2 diabetic patients
Tools
Harte, A. L. (Alison L.), Al-Daghri, N. M., Al-Rubeaan, K., Al-Attas, Omar S., da Silva, N. F., Sabico, Shaun, Kumar, Sudhesh and McTernan, P. G. (Philip G.) (2007) Rosiglitazone as a therapeutic agent to reduce inflammatory risk in type 2 diabetic patients. In: 43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Amsterdam, Netherlands, September 18-21, 2007. Published in: Diabetologia, Vol.50 (Supplement.1). S272-S273.
Full text not available from this repository.
Official URL: http://dx.doi.org/10.1007/s00125-007-0809-7
| Item Type: | Conference Item (Poster) |
|---|---|
| Subjects: | R Medicine > RC Internal medicine |
| Divisions: | Faculty of Medicine > Warwick Medical School |
| Journal or Publication Title: | Diabetologia |
| Publisher: | Springer |
| ISSN: | 0012-186X |
| Date: | September 2007 |
| Volume: | Vol.50 |
| Number: | Supplement.1 |
| Number of Pages: | 2 |
| Page Range: | S272-S273 |
| Identification Number: | 10.1007/s00125-007-0809-7 |
| Status: | Not Peer Reviewed |
| Publication Status: | Published |
| Access rights to Published version: | Restricted or Subscription Access |
| Conference Paper Type: | Poster |
| Title of Event: | 43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes |
| Type of Event: | Other |
| Location of Event: | Amsterdam, Netherlands |
| Date(s) of Event: | September 18-21, 2007 |
| URI: | http://wrap.warwick.ac.uk/id/eprint/31529 |
Data sourced from Thomson Reuters' Web of Knowledge
Actions (login required)
![]() |
View Item |
Tools
Tools

